A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer

Japanese Journal of Clinical Oncology

Volumn 39, Issue 1, 2009, Pages 37-42

  Nakajima, Takako Eguchi ^a   Ura, Takashi ^b   Ito, Yoshinori ^a   Kato, Ken ^a   Minashi, Keiko ^c   Nihei, Keiji ^c   Hironaka, Shuichi ^d   Boku, Narikazu ^d   Kagami, Yoshikazu ^a   Muro, Kei ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^d SHIZUOKA CANCER CENTER   (Japan)

Author keywords

5 fluorouracil; Chemoradiotherapy; Cisplatin; Esophageal cancer; Japanese

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER STAGING; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG FEVER; DRUG RESPONSE; DYSPHAGIA; DYSPNEA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS CANCER; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION; JAPAN; JAPANESE; LEUKOCYTE COUNT; MALE; MAXIMUM TOLERATED DOSE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPHIL COUNT; PERICARDIAL EFFUSION; PERICARDITIS; PHASE 1 CLINICAL TRIAL; PLEURA EFFUSION; POTASSIUM BLOOD LEVEL; RADIATION DOSE; RADIATION PNEUMONIA; SIDE EFFECT; SODIUM BLOOD LEVEL; STOMATITIS; THROMBOCYTE COUNT;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM STAGING;

EID: 58149400520     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn125     Document Type: Article

References (22)

1. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74.
2. Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: A Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol 2004;34:615-9.
3. Minashi K, Muro K, Kato K, Ohtsu A, Ishkura S, Boku N, et al. A phase II study of chemoradiotherapy in patients (pts) with stage II-III esophageal squamous cell carcinoma (ESCC): Japan Clinical Oncology Group trial (JCOG 9906). In: Gastrointestinal Cancers Symposium. Orland: American Society of Clinical Oncology 2008.
4. Sobin L, Witteking C. Classification of malignant tumours. 6th edn. New Jersey: International Union Against Cancer (UICC) 2002.
5. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. J Am Med Assoc 1999;281:1623-7.
6. Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg RJ, Pajak T, et al. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1999;43:517-23.
7. Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg R, Benson A, 3rd. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: A preliminary analysis of the phase II intergroup trial 0122. J Clin Oncol 1996;14:149-55.
8. Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M. A phase I/ II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): Final report. Cancer 2000;88:988-95.
9. Cwikiel M, Albertsson M, Hambraeus G. Acute and delayed effects of radiotherapy in patients with oesophageal squamous cell carcinoma treated with chemotherapy, surgery and pre- and postoperative radiotherapy. Acta Oncol 1994;33:49-53.
10. Gergel T, Proulx G, Leichman L, Nava H, Kuettel M. Diagnostic dilemmas in oncology: Case 3. Pericardial effusion after esophageal radiation. J Clin Oncol 2001; 19:4344-5.
11. Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003;21:2697-702.
12. Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases. Hum Pathol 1996;27:766-73.
13. Byhardt R, Brace K, Ruckdeschel J, Chang P, Martin R, Wiernik P. Dose and treatment factors in radiation-related pericardial effusion associated with the mantle technique for Hodgkin's disease. Cancer 1975;35:795-802.
14. Totterman KJ, Pesonen E, Siltanen P. Radiation-related chronic heart disease. Chest 1983;83:875-8.
15. Boivin JF, Hutchison GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992;69:1241-7.
16. Corn BW, Trock BJ, Goodman RL. Irradiation-related ischemic heart disease. J Clin Oncol 1990;8:741-50.
17. Joensuu H. Acute myocardial infarction after heart irradiation in young patients with Hodgkin's disease. Chest 1989;95:388-90.
18. Rodriguez-Garcia JL, Fraile G, Moreno MA, Sanchez-Corral JA, Penalver R. Recurrent massive pleural effusion as a late complication of radiotherapy in Hodgkin's disease. Chest 1991;100:1165-6.
19. Morrone N, Gama e Silva Volpe VL, Dourado AM, Mitre F, Coletta EN. Bilateral pleural effusion due to mediastinal fibrosis induced by radiotherapy. Chest 1993;104:1276-8.
20. Imdahl A, Schoffel U, Ruf G. Impact of neoadjuvant therapy of perioperative morbidity in patients with esophageal cancer. Am J Surg 2004;187:64-8.
21. Balart J, Balmana J, Rius X, Salazar R, Gallen M, Navarro S, et al. Treatment of oesophageal cancer with preoperative chemoradiotherapy may increase operative mortality. Eur J Surg Oncol 2003;29:884-9.
22. Lee H, Vaporciyan A, Cox J, Tucker SL, Putnam JB, Jr, Ajani JA. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: Correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 2003;57:1317-22.